Kalos Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-182
| Closed | -$9.85K | – | 196 |
|
|
2023
Q1 | $9.85K | Buy |
+182
| New | +$9.85K | 0.02% | 212 |
|
|
2022
Q1 | – | Sell |
-45,919
| Closed | -$2.39M | – | 211 |
|
|
2021
Q4 | $2.39M | Buy |
45,919
+3,401
| +8% | +$177K | 0.65% | 29 |
|
|
2021
Q3 | $2.21M | Sell |
42,518
-6,813
| -14% | -$355K | 0.63% | 29 |
|
|
2021
Q2 | $3.17M | Sell |
49,331
-64
| -0.1% | -$4.12K | 1.29% | 9 |
|
|
2021
Q1 | $3.43M | Buy |
49,395
+1,828
| +4% | +$127K | 1.07% | 13 |
|
|
2020
Q4 | $3.11M | Sell |
47,567
-3,255
| -6% | -$213K | 1.33% | 10 |
|
|
2020
Q3 | $2.91M | Sell |
50,822
-2,466
| -5% | -$141K | 1.3% | 14 |
|
|
2020
Q2 | $2.79M | Sell |
53,288
-3,327
| -6% | -$174K | 1.17% | 19 |
|
|
2020
Q1 | $3.08M | Sell |
56,615
-20,288
| -26% | -$1.1M | 1.37% | 12 |
|
|
2019
Q4 | $4.24M | Sell |
76,903
-3,021
| -4% | -$166K | 1.54% | 11 |
|
|
2019
Q3 | $4.02M | Sell |
79,924
-11,504
| -13% | -$579K | 1.6% | 10 |
|
|
2019
Q2 | $4.49M | Buy |
91,428
+5,379
| +6% | +$264K | 2.04% | 10 |
|
|
2019
Q1 | $4M | Sell |
86,049
-5,484
| -6% | -$255K | 2.58% | 9 |
|
|
2018
Q4 | $4.49M | Sell |
91,533
-5,310
| -5% | -$261K | 2.19% | 10 |
|
|
2018
Q3 | $6M | Sell |
96,843
-4,002
| -4% | -$248K | 3.22% | 6 |
|
|
2018
Q2 | $5.42M | Sell |
100,845
-64
| -0.1% | -$3.44K | 2.46% | 3 |
|
|
2018
Q1 | $4.58M | Buy |
100,909
+5,229
| +5% | +$238K | 2.71% | 8 |
|
|
2017
Q4 | $3.76M | Buy |
95,680
+2,786
| +3% | +$110K | 1.77% | 7 |
|
|
2017
Q3 | $3.43M | Buy |
92,894
+11,215
| +14% | +$413K | 2.21% | 6 |
|
|
2017
Q2 | $3.14M | Buy |
81,679
+3,236
| +4% | +$125K | 2.87% | 2 |
|
|
2017
Q1 | $2.67M | Buy |
78,443
+13,168
| +20% | +$449K | 1.89% | 12 |
|
|
2016
Q4 | $2.14M | Buy |
65,275
+11,860
| +22% | +$389K | 1.73% | 15 |
|
|
2016
Q3 | $1.72M | Buy |
53,415
+6,710
| +14% | +$217K | 1.47% | 20 |
|
|
2016
Q2 | $1.44M | Buy |
+46,705
| New | +$1.44M | 1.12% | 28 |
|